Chargement en cours...
HMGB1 in Radiotherapy: A Two Headed Signal Regulating Tumor Radiosensitivity and Immunity
Radiotherapy (RT) is a mainstay of cancer treatment. Recent studies have shown that RT not only directly induces cell death but also has late and sustained immune effects. High mobility group box 1 (HMGB1) is a nuclear protein released during RT, with location-dependent functions. It is essential fo...
Enregistré dans:
| Publié dans: | Onco Targets Ther |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7369309/ https://ncbi.nlm.nih.gov/pubmed/32764978 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S253772 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|